Dry Eye is more than an inconvenience. Dry Eye is a disease

Many people suffer for years from the discomfort and pain of Dry Eye Disease Most try various products to manage their disease, and while many of the Over-The-Counter products can provide relief, it is just temporary symptom relief.

Meibomian Gland Dysfunction (MGD) is a leading cause of Dry Eye Disease. Dry Eye Disease is rarely due to a lack of the watery part of your tears. 86% of dry eye patients have MGD.

What is Meibomian Gland Dysfunction?

Meibomian Gland Dysfunction is a progressive disease of the ocular surface. Long term, failure to treat MGD can lead to chronic discomfort and degradation of vision, significantly impacting quality of life.

Healthy Meibomian glands that line your upper and lower eyelids secrete oil with every blink. Your Meibomian glands produce the oily part of the tear film needed to protect the surface of your eye by preventing the evaporation of the watery part of your tears. When this function is not working well, your eyes may feel dry. Keeping the function and structure of your Meibomian glands healthy before you become symptomatic is key, as MGD progresses over time.

What Causes MGD?

MGD is caused by anatomical changes in the Meibomian glands. If left untreated, MGD can become progressively worse over time.

Conditions that can contribute to MGD:

Talk To Your Doctor About TearScience® LipiFlow®

Dry Eyes? Don’t just treat your symptoms, Treat the Cause and MOVE FORWARD with MGD treatment with TearScience® LipiFlow®.

For patients with MGD, TearScience® LipiFlow® significantly improves gland secretions and ocular surface symptoms including dry eye and less frequent or blurry vision.

  • The treatment is non-invasive procedure performed in the comfort of your doctor’s office, only takes 12 minutes and can have long-lasting results
  • After initial anesthetic drops, no drugs required for TearScience® LipiFlow® treatment
  • Long-lasting results—many can see the continued benefit up to 12 months
  • 400,000 treatments worldwide—and growing

Just 1 treatment increases mean gland secretion 3-fold and reduces more than 50% dry eye symptoms. Treatment also increased patient comfortable contact lens wear time by approximately 4 hours on average per day.

TearScience® LipiFlow® treatment prior to cataract surgery improves mean dry eye symptomsand vision-related function scores post-surgery. Choose TearScience® LipiFlow®, because Eye Health Starts at the Surface.

BlephEx